Exprese MMP-26 v endometriálních explantech pod vlivem estradiolu a progesteronu
[MMP-26 expression in endometrial explants treated with estradiol and progesterone]
Jazyk čeština Země Česko Médium print
Typ dokumentu anglický abstrakt, časopisecké články
PubMed
15633416
- MeSH
- dospělí MeSH
- endometrium účinky léků metabolismus MeSH
- estradiol farmakologie MeSH
- folikulární fáze MeSH
- lidé MeSH
- matrixové metaloproteinasy metabolismus MeSH
- metaloproteinasy secernované do matrix MeSH
- progesteron farmakologie MeSH
- techniky in vitro MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- anglický abstrakt MeSH
- časopisecké články MeSH
- Názvy látek
- estradiol MeSH
- matrixové metaloproteinasy MeSH
- metaloproteinasy secernované do matrix MeSH
- MMP26 protein, human MeSH Prohlížeč
- progesteron MeSH
OBJECTIVE: To examine possible estrogen dependent endometrial expression of MMP-26 in vitro. DESIGN: Experimental study. SETTING: Department of Obstetrics and Gynecology of the Palacky University Medical School and University Hospital, Olomouc, Czech Republic, Department of Obstetrics and Gynecology, University Hospital, Lund, Sweden. METHODS: We studied MMP-26 mRNA in 14 normal endometrial samples obtained from the proliferative phase of the menstrual cycle. Samples were cultured for five days either with estradiol alone or in combination with progesterone. Samples cultured with ethanol represented control groups. MMP-26 mRNA expression was examined in frozen samples using in situ hybridization. Immunohistochemistry was used to study the presence of estrogen and progesterone receptors in endometrial explants. RESULTS: MMP-26 mRNA expression was highest in fresh (non cultured) samples. Signal intensity decreased during the first two days of culture and was negligable in the following days. Nuclear intensity for estrogen and progesterone receptor was high after five days of culture. CONCLUSION: We did not find MMP-26 mRNA in vitro expression to be directly estrogen dependent.